Holm-Jorgensen Rasmus 4
4 · Acrivon Therapeutics, Inc. · Filed Nov 18, 2024
Insider Transaction Report
Form 4
Holm-Jorgensen Rasmus
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-11-14$7.92/sh−368$2,915→ 26,522 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.